++
Chapter 17. Breast Disorders
++
++
++
Fibrocystic condition of the breast is
++
++
++
++
++
B. Common in postmenopausal women
++
++
C. Caused at least in part by estrogen stimulation of breast tissue
++
++
D. Carries a threefold increased risk of breast cancer
++
++
E. Does not actually include any cysts on histology
+
++
C. Caused at least in part by estrogen stimulation of breast tissue
++
++
++
Risk factors for breast cancer include
++
++
++
++
++
++
++
C. BRCA1 mutation only in families of Ashkenazi Jewish descent
++
++
D. A personal history of breast cancer
++
++
+
++
D. A personal history of breast cancer
++
++
++
Breast cancer screening in asymptomatic women
++
++
++
A. Identifies about 2 cancers per 1000 women over age 50 years
++
++
B. Identifies cancer without node involvement in about 80% of detected cases
++
++
C. Includes a history, physical examination, bilateral mammogram, and ultrasound for women between ages 40 and 50 years
++
++
D. Is followed by a 5-year survival of 95% for women diagnosed through screening
++
++
E. Should include all women yearly after the age of 30 years
+
++
B. Identifies cancer without node involvement in about 80% of detected cases
++
++
++
The clinical findings at breast cancer presentation most commonly include
++
++
++
A. A painless mass identified by the patient
++
++
B. A new mass discovered during a clinician physical examination (60% of cases)
++
++
C. Nipple discharge (60% of cases)
++
++
D. An axillary mass due to metastatic lymph nodes (40% of cases)
++
++
+
++
A. A painless mass identified by the patient
++
++
++
Axillary lymph node metastases from breast cancer
++
++
++
A. Are not important for predicting patient survival in women with breast cancer
++
++
B. Are generally palpable if present
++
++